Brief: India Globalization Capital- Presently Cannot Estimate The Full Potential Impact Of Covid-19 On Co

IGC Pharma

16/03/2020 12:00

March 16 (Reuters) - India Globalization Capital Inc
 IGC.A :
    * INDIA GLOBALIZATION CAPITAL- PRESENTLY CANNOT ESTIMATE THE
FULL
POTENTIAL IMPACT OF COVID-19 ON CO
    * INDIA GLOBALIZATION CAPITAL- REVENUE FROM INFRASTRUCTURE
BUSINESS REMAINS AFFECTED FROM COVID-19
    * INDIA GLOBALIZATION CAPITAL- LAUNCH OF SOME OF OUR BRANDS
IS
DELAYED DUE TO DISRUPTION FROM COVID-19
    * INDIA GLOBALIZATION CAPITAL-  ACTIVELY NEGOTIATING SHARE
PURCHASE AGREEMENT WITH SHAREHOLDERS OF EVOLVE TO BUY REMAINING
COMMON STOCK OF EVOLVE
    * INDIA GLOBALIZATION CAPITAL- AT CLOSING OF SHARE PURCHASE
AGREEMENT, EXPECTS TO PAY $229,590 IN CASH, 22,040 SHARES OF
COMMON STOCK OF CO
    * INDIA GLOBALIZATION CAPITAL-ABOUT $300,000 IN CASH, 
300,000
SHARES OF COMMON STOCK OF CO WOULD BE PAYABLE ON ACHIEVEMENT OF
VARIOUS OPERATIONAL GOALS

Source text for Eikon: https://bit.ly/2vorvNq
Further company coverage:  IGC.A 

 ((Briefs@thomsonreuters.com;))